// App-Quantinova.ai

13855 2014 AHA : The Impact of Plasma Levels of Receptor for Advanced Glycation End-products and High Mobility Group Box 1 in Patients With Pulmonary Hypertension

Researchers

Presenter

  • Kazuhiko Nakazato

Principal Investigators

  • Koichi Sugimoto

  • Akiomi Yoshihisa

  • Takayoshi Yamaki

  • Hiroyuki Kunii

  • Hitoshi Suzuki

  • Shu-ichi Saitoh

  • Yasuchika Takeishi

Medical Centers

  • Fukusima Medical University, Fukushima, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Right ventricular failure

  • Pulmonary arterial hypertension

  • Venous thrombosis

  • Hypertension

  • Chronic thromboembolic pulmonary hypertension

Biomarkers

  • Advanced Glycosylation End-Product Specific Receptor

  • High Mobility Group Box 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim